Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to create new guidance around expensive drugs, as compounded GLP-1s are set to be ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

Ozempic/Wegovy is the first drug on HHS's 2025 ... life-saving treatments at lower costs." According to HHS's announcement, these drugs were used by 5.3 million Medicare Part D recipients between ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

The cost of medical treatment of diabetes is now at the centre of a debate in US politics ... such as the approval of Novo Nordisk’s Ozempic (semaglutide injection) and Eli Lilly’s Trulicity ...

That leaves people in states such as Florida and California scrambling to find coverage and increasingly failing to do so. It also leaves a system known as “insurers of last resort” — state ...